The Truong lab investigates the possibilities of our genomes by writing in synthetic DNA hundreds of kilobases at a time.
This capability will enable us to build sophisticated cellular programs — arming our cells with functionalities to perhaps fight cancer, autoimmune disease, neurodegeneration, or age-related diseases.
We engineer human pluripotent stem cells (iPSCs), the
start of all other cells. We then coax them
into immune cells as living therapies or
tissue cells for regenerative medicine.
We aspire to codify the grammar
and language of cellular
Make better, safer and more accessible cell therapies and regenerative medicines by manipulating the genome.
Inclusion, Respect, Understanding, Integrity, Impact, Innovation, Creativity, Wonder, Work-Life Balance
Synthetic Genomes and Cell Therapies
The Truong lab will be hiring one additional PhD student this year.
The Truong lab celebrates it's 1 year anniversary!
The Truong Lab has been awarded an NIH Director's New Innovator award (DP2) from the National Institute of Allergy and Infectious Diseases (NIAID) for 5 years.